Clindamycin for Bacterial Vaginosis
Yes, clindamycin is an appropriate and FDA-approved treatment for bacterial vaginosis, though metronidazole regimens are generally preferred as first-line therapy due to superior efficacy.
Treatment Hierarchy
First-Line Therapy (Non-Pregnant Women)
While clindamycin is effective, metronidazole 500 mg orally twice daily for 7 days remains the preferred first-line treatment 1. The CDC guidelines consistently position metronidazole regimens as recommended therapy, with clindamycin as an alternative option 1.
When to Use Clindamycin
Clindamycin is the preferred choice in these specific situations:
- Metronidazole allergy or intolerance - This is the primary indication where clindamycin becomes first-line 1
- First trimester pregnancy - Clindamycin vaginal cream 2% is preferred over oral clindamycin to minimize fetal exposure 2
- Patient preference for intravaginal therapy - Some women prefer topical treatment to avoid systemic side effects like GI upset 2
Clindamycin Regimens
Recommended Options 1:
- Clindamycin cream 2%: One full applicator (5g) intravaginally at bedtime for 7 days
- Clindamycin 300 mg orally: Twice daily for 7 days (alternative regimen)
- Clindamycin ovules 100g: Intravaginally once at bedtime for 3 days (alternative)
Efficacy Considerations
Important caveat: Vaginal clindamycin cream appears less efficacious than metronidazole regimens 1. The cure rates at 4 weeks post-treatment show metronidazole oral (78%) versus clindamycin vaginal cream (82%) are comparable, but the 2002 guidelines explicitly note clindamycin cream's lower efficacy 1.
Special Populations
Pregnancy
- All symptomatic pregnant women should be treated 1
- Avoid clindamycin cream in pregnancy - Three trials showed increased adverse events (prematurity, neonatal infections) with clindamycin cream use during pregnancy 1
- Use oral clindamycin 300 mg twice daily for 7 days instead if metronidazole cannot be used 1
- For high-risk pregnant women (prior preterm birth), systemic therapy is preferred to treat potential subclinical upper tract infection 1
Pre-Surgical Screening
Screen and treat BV before surgical abortion or hysterectomy to reduce postoperative infectious complications by 10-75% 1. Treatment with metronidazole substantially reduced post-abortion PID in randomized trials 1.
Practical Considerations
Advantages of Clindamycin
- Minimal systemic absorption with vaginal cream (mean bioavailability ~4%) 2
- Avoids metronidazole's GI side effects and alcohol restriction 2
- Single-dose bioadhesive formulations show high acceptability (91% satisfaction) 3
Disadvantages
- Oil-based cream weakens latex condoms and diaphragms 1 - critical counseling point
- Lower cure rates than metronidazole in some studies 1
- 50-80% recurrence rate within one year (similar to all BV treatments) 4, 5
Recurrent BV
For recurrent disease, extended metronidazole therapy (500 mg twice daily for 10-14 days, then vaginal gel twice weekly for 3-6 months) is recommended 5. Clindamycin can be used as an alternative if metronidazole fails or is not tolerated 5.
Key Clinical Pitfalls
- Do not treat sexual partners - Multiple trials show no benefit on cure or recurrence rates 1
- No follow-up needed if asymptomatic - except in high-risk pregnant women at 1 month 1
- Do not use vaginal clindamycin in pregnancy due to adverse neonatal outcomes 1
- Warn about condom/diaphragm interaction with cream formulations 1